Covalent Docking in Drug Discovery: Scope and Limitations.

Area of Science:

• Medicinal Chemistry
• Computational Drug Design
• Pharmacology

Background:

• Covalent inhibitors form a chemical bond with target proteins, offering potential advantages in affinity and selectivity over non-covalent drugs.
• The rise in covalent drug discovery has spurred the development of specialized computational tools, particularly covalent docking methods.

Purpose of the Study:

• To provide a comprehensive analysis of state-of-the-art covalent docking programs for predicting covalent ligand binding.
• To highlight the features, limitations, and algorithmic differences in current covalent docking tools.
• To identify best practices for computer-aided covalent drug design and virtual screening applications.

Main Methods:

• Review and analysis of existing covalent docking algorithms and software.
• Comparison of methods for modeling covalent bond formation and its impact on binding predictions.
• Discussion of retrospective and prospective covalent docking-based virtual screening studies.

Main Results:

• Current covalent docking tools integrate non-covalent docking with specific modeling of the covalent bond formation at the reaction site.
• Significant variations exist in how different programs handle the covalent bond formation, impacting prediction accuracy.
• Successful applications of covalent docking in virtual screening demonstrate its utility in identifying novel covalent binders.

Conclusions:

• Covalent docking is a valuable computational approach for advancing covalent drug design.
• Understanding the nuances of different algorithms is crucial for optimizing predictions and identifying best practices.
• Further improvements in computational methods are needed to fully realize the potential of computer-aided covalent drug design.